Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines
H. Dostalova, R. Jorda, E. Reznickova, V. Krystof
This study investigates the anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines and finds it inhibits HER2 signaling and downstream kinases.
bioRxiv · Feb 23, 2023Cancer Biology